Skip to content

Effect of Lactobacillus Rhamnosus GG (LGG) on Infant Colic

Effect of Lactobacillus Rhamnosus GG (LGG) on Infant Crying, Intestinal Microbiota, and Intestinal Inflammation in Infants With Colic

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01279265
Acronym
LGG
Enrollment
30
Registered
2011-01-19
Start date
2011-09-30
Completion date
2013-01-31
Last updated
2015-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colic, Inflammation

Keywords

Lactobacillus, Probiotic, Crying time, Fecal microbiota, Calprotectin, Colic, Infant Crying, Barr Diary, Breath Hydrogen, Clinical Design

Brief summary

This study will compare 2 currently marketed formulas in healthy full term babies: Nutramigen A+ (a hypoallergenic formula) and Nutramigen-Enflora (hypoallergenic formula with Lactobacillus GG (LGG)) during 3 months of formula feeding. The investigators' aims are to compare 3 outcomes in these babies: (1) normal baby crying time; (2) the composition of intestinal microbiota (bacteria in the stool); and (3) a lab test which measures the number of white blood cells in the large intestine (fecal calprotectin). The investigators predict that LGG supplementation (Nutramigen-Enflora) will facilitate its establishment as an important component of the neonatal intestinal microbial community and reduce fecal calprotectin.

Interventions

DIETARY_SUPPLEMENTNutramigen with Enflora

Hypoallergenic formula with probiotic - Lactobacillus GG

DIETARY_SUPPLEMENTNutramigen A+

Hypoallergenic formula without lactobacillus

Sponsors

Mead Johnson Nutrition
CollaboratorINDUSTRY
The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
3 Weeks to 3 Months
Healthy volunteers
Yes

Inclusion criteria

* Sixty healthy full-term colicky infants (gestational age 32 wks to 41 wks)

Exclusion criteria

* chronic lung disease, * diarrhea (stools that take the shape of a container \> 5x daily) * fever

Design outcomes

Primary

MeasureTime frameDescription
Daily Average Crying and Fussing Duration According to Barr Diary Records90 daysThe parent or guardian will complete a Barr diary to measure crying and fussing times of colicky infants . It is a daily timeline that records the number of minutes in five minute increments with fussiness and crying. The average colicky infant cries and fusses is more than 3 hours daily. If infants surpasses the 3 hours for more than three days (not consecutive) and are less than 3 months of age, they are considered to have colic.

Secondary

MeasureTime frameDescription
Fecal Microbiota90 daysAnalyze and identify bacteria in the stool of the subjects. We will use pyrosequencing to characterize the bacteria colonizing the stool. We will measure diversity by Shannon's diversity index in the two groups.
Fecal Calprotectin90 daysTest intestinal inflammation in the infants. Calprotectin is made by white blood cells called neutrophils. The number of neutrophils in the intestine is reflected by the fecal calprotectin level.

Countries

United States

Participant flow

Participants by arm

ArmCount
Nutramigen Lipil With Enflora
Nutramigen with Enflora: Hypoallergenic formula with probiotic - Lactobacillus GG
9
Nutramigen A+
Hypoallergenic formula without lactobacilli Nutramigen A+: Hypoallergenic formula without lactobacillus
11
Total20

Baseline characteristics

CharacteristicNutramigen Lipil With EnfloraNutramigen A+Total
Age, Categorical
<=18 years
9 Participants11 Participants20 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
3 Participants4 Participants7 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
6 Participants7 Participants13 Participants
Region of Enrollment
United States
9 participants11 participants20 participants
Sex: Female, Male
Female
4 Participants4 Participants8 Participants
Sex: Female, Male
Male
5 Participants7 Participants12 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 90 / 11
serious
Total, serious adverse events
0 / 90 / 11

Outcome results

Primary

Daily Average Crying and Fussing Duration According to Barr Diary Records

The parent or guardian will complete a Barr diary to measure crying and fussing times of colicky infants . It is a daily timeline that records the number of minutes in five minute increments with fussiness and crying. The average colicky infant cries and fusses is more than 3 hours daily. If infants surpasses the 3 hours for more than three days (not consecutive) and are less than 3 months of age, they are considered to have colic.

Time frame: 90 days

ArmMeasureValue (MEAN)
Nutramigen Lipil With EnfloraDaily Average Crying and Fussing Duration According to Barr Diary Records111 minutes
Nutramigen A+Daily Average Crying and Fussing Duration According to Barr Diary Records133 minutes
Secondary

Fecal Calprotectin

Test intestinal inflammation in the infants. Calprotectin is made by white blood cells called neutrophils. The number of neutrophils in the intestine is reflected by the fecal calprotectin level.

Time frame: 90 days

ArmMeasureGroupValue (MEAN)
Nutramigen Lipil With EnfloraFecal CalprotectinVisit 2 - Day 14226 µg/g (feces)
Nutramigen Lipil With EnfloraFecal CalprotectinVisit 1- Baseline285 µg/g (feces)
Nutramigen Lipil With EnfloraFecal CalprotectinVisit 3 - Day 42229 µg/g (feces)
Nutramigen Lipil With EnfloraFecal CalprotectinVisit 4 - Day 90211 µg/g (feces)
Nutramigen A+Fecal CalprotectinVisit 4 - Day 90332 µg/g (feces)
Nutramigen A+Fecal CalprotectinVisit 3 - Day 42250 µg/g (feces)
Nutramigen A+Fecal CalprotectinVisit 1- Baseline294 µg/g (feces)
Nutramigen A+Fecal CalprotectinVisit 2 - Day 14305 µg/g (feces)
Secondary

Fecal Microbiota

Analyze and identify bacteria in the stool of the subjects. We will use pyrosequencing to characterize the bacteria colonizing the stool. We will measure diversity by Shannon's diversity index in the two groups.

Time frame: 90 days

ArmMeasureGroupValue (MEAN)Dispersion
Nutramigen Lipil With EnfloraFecal MicrobiotaVisit 1 - Baseline.946 Shannon's diversity index valueStandard Deviation 0.927
Nutramigen Lipil With EnfloraFecal MicrobiotaVisit 2- Day 141.314 Shannon's diversity index valueStandard Deviation 0.789
Nutramigen Lipil With EnfloraFecal MicrobiotaVisit 3 - Day 421.047 Shannon's diversity index valueStandard Deviation 0.35
Nutramigen Lipil With EnfloraFecal MicrobiotaVisit 4 - Day 90.676 Shannon's diversity index valueStandard Deviation 0.444
Nutramigen A+Fecal MicrobiotaVisit 4 - Day 90.737 Shannon's diversity index valueStandard Deviation 0.409
Nutramigen A+Fecal MicrobiotaVisit 1 - Baseline.991 Shannon's diversity index valueStandard Deviation 0.415
Nutramigen A+Fecal MicrobiotaVisit 3 - Day 421.161 Shannon's diversity index valueStandard Deviation 0.612
Nutramigen A+Fecal MicrobiotaVisit 2- Day 14.537 Shannon's diversity index valueStandard Deviation 0.289

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026